CRISPR Medicine News, 7 December 2020 | Fast CRISPR 'lab-on-a-chip' detects COVID19 - CRISPR Medicine

Pick of the Month

Last month, in a new exciting CRISPR first, scientists developed what could become a one-time CRISPR-Cas9 treatment for Angelman syndrome that would replace frequent, invasive injections. We interviewed neurobiologist Mark Zylka, who led the study, and Dr Arthur Beaudet, a paediatrician and molecular geneticist not involved in the study, to hear what this means for current and future patients. If you missed the story, you have another chance to catch it here.

Fast CRISPR 'lab-on-a-chip' detects COVID19 in just over half an hour
More potential good news on detecting and stopping the COVID19 pandemic. Scientists at Stanford have developed a new electric field-driven microfluidic 'lab-on-a-chip' which use CRISPR-Cas12 to rapidly detect the SARS-CoV-2 in nasal-swap samples. The device is portable and can be used in the field with high accuracy and the chip cost as little as $5.

Career CRISPR Medicine

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at We love hearing from readers!

Happy Reading!


p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.